All News

Mel Mann, the longest living person who participated in the clinical trial for Gleevec – which was approved by the FDA just over 20 years ago – shares what he would tell his younger self.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Rose Gerber, a breast cancer survivor and advocate, about disparities in cancer care, in particular in breast cancer.

After her sister's cancer recurrence, a woman explains her choice not to assume the caregiver role this time around. "While my sister battles cancer this time, I will be her sister," she writes.

In our cancer myths quiz, you’ll get to test your knowledge on common misconceptions about cancer.

Liposarcoma survivor Arianne Missimer discusses the training process for ‘American Ninja Warrior’ and how she felt the day of competition.

Here are five options for overcoming stress and anxiety to promote your mental wellness and emotional resilience during your radiation therapy.

"In the three years since her diagnosis, Lisa has become a champion for those with lung cancer, raising money for research and advocating for policies to find new treatments and cures."

“We are fortunate now to live in an era where we have nine new drugs approved (for AML) just in the last five years,” says an expert from The University of Texas MD Anderson Cancer Center.

A retired special education teacher reflects on a pediatric oncology nurse practitioner who helped her teach children with neurocognitive issues impacted by cancer and its treatments.

The potential for a measles and mumps outbreak in the United States may be life threatening for patients with cancer who are immunocompromised.

A cancer survivor describes the mixed emotions she feels while in remission.

The FDA granted approval to Welireg for the treatment of patients with von Hippel-Lindau-associated kidney cancer, CNS hemangioblastomas and pancreatic neuroendocrine tumors.

From the state of the “Tiger King’s” Joe Exotic’s prostate cancer to the emotional reunion of two 3-year-old cancer survivors, here’s what’s happening in the cancer landscape this week.

The FDA determined that individuals with weakened immune systems — which include patients with cancer — may benefit from a third dose of Pfizer-BioNTech’s and Moderna’s COVID-19 vaccines.

On behalf of Hope for Stomach Cancer, Dr. Yanghee Woo speaks with CURE® about risk factors for gastric cancer and the alarming rise in cases in young adults.

Adolescent and young adult patients are more represented than previously expected in clinical trials. However, their outcomes still lag behind the younger and older populations.

Multiple cancer drugs have been approved by the FDA in the last few months.

A four-time cancer survivor shares the advice her father gave her as a young child during her first journey with cancer. The words he uttered made her shift how she has looked at life.

In this episode of the “CURE® Talks Cancer” podcast, the hosts of the ‘Stage 4 Clinger’ podcast share the story of their cancer and caregiver journeys and how it led to the conception of their podcast.

Cancer survivors who identify as LGBTQ reported a lack of access to tailored resources and support groups and fear of discrimination.

Patients on Keytruda/Lenvima lived for an average of 23.9 months without their disease progressing, compared to those on a different treatment, with an average of 9.3 months.

The COVID-19 pandemic may have worsened existing health disparities in cancer care. Vaccines may be the next step forward.

An oncologist writes about the valuable contributions of another oncologist in the field.

“More and more (patients and physicians) need to work together in partnership throughout the cancer journey in order to optimize and make the journey the best possible that we can for every single patient,” says an expert from the Roswell Park Comprehensive Cancer Center.

A woman shares her thoughts on the number of oral medications she's taken to treat her metastatic breast cancer.

There are now more oral cancer treatments than ever, highlighting the importance of patients independently taking their drugs as prescribed.

Heating chemotherapy and administering it into the abdominal cavity allows children with desmoplastic small round cell tumors to be treated with minimal side effects.

The FDA will speed up the review of Keytruda to treat patients with kidney cancer after they’ve undergone surgery.